Evidence map›Paper›PMID 24509781›Full record

ArticleNature reviews. Microbiology2014

Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance.

Namraj Goire, Monica M Lahra, Marcus Chen, Basil Donovan, Christopher K Fairley, Rebecca Guy, John Kaldor, David Regan, James Ward, Michael D Nissen and 2 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature reviews. Microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Surveillance systems to monitor antimicrobial resistance inEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Pooled it
  2. Trial
  3. Maximizing theJournal of clinical microbiology · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Microbial genomics · 2021
    Article
  10. Multidrug-Resistant Bacteria in the Community: An Update.Infectious disease clinics of North America · 2020
    Review
  11. Article
  12. Azithromycin resistant gonococci: a literature review.Antimicrobial resistance and infection control · 2020
    Review
  13. The Laboratory Diagnosis ofPathogens (Basel, Switzerland) · 2020
    Review
  14. ShanghaiFrontiers in microbiology · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Culture-free genotyping ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Namraj GoireQueensland Paediatric Infectious Diseases Laboratory and Queensland Children's Medical Research Institute, Royal Children's Hospital, The University of Queensland, Brisbane, Queensland 4029, Australia.
Monica M LahraWHO Collaborating Centre for Sexually Transmitted Diseases and HIV, Microbiology Department, South Eastern Area Laboratory Services, Prince of Wales Hospital, Sydney, New South Wales 2031, Australia.
Marcus ChenMelbourne Sexual Health Centre, Alfred Health, Carlton Victoria 3053, Australia and Melbourne School of Population Health, University of Melbourne, Victoria 3010, Australia.
Basil Donovan1] Kirby Institute, University of New South Wales, Sydney, New South Wales 2052, Australia. [2] Sydney Sexual Health Centre, Sydney Hospital, Sydney New South Wales 2000, Australia.
Christopher K FairleyMelbourne Sexual Health Centre, Alfred Health, Carlton Victoria 3053, Australia and Melbourne School of Population Health, University of Melbourne, Victoria 3010, Australia.
Rebecca GuyKirby Institute, University of New South Wales, Sydney, New South Wales 2052, Australia.
John KaldorKirby Institute, University of New South Wales, Sydney, New South Wales 2052, Australia.
David ReganKirby Institute, University of New South Wales, Sydney, New South Wales 2052, Australia.
James WardBaker IDI Central Australia, Alice Springs, Northern Territory 0870, Australia.
Michael D Nissen1] Queensland Paediatric Infectious Diseases Laboratory and Queensland Children's Medical Research Institute, Royal Children's Hospital, The University of Queensland, Brisbane, Queensland 4029, Australia. [2] Microbiology Division, Pathology Queensland Central, Royal Brisbane and Women's Hospital Campus, Queensland 4006, Australia.
Theo P Sloots1] Queensland Paediatric Infectious Diseases Laboratory and Queensland Children's Medical Research Institute, Royal Children's Hospital, The University of Queensland, Brisbane, Queensland 4029, Australia. [2] Microbiology Division, Pathology Queensland Central, Royal Brisbane and Women's Hospital Campus, Queensland 4006, Australia.
David M WhileyQueensland Paediatric Infectious Diseases Laboratory and Queensland Children's Medical Research Institute, Royal Children's Hospital, The University of Queensland, Brisbane, Queensland 4029, Australia.
UNSW Sydney · AUChildren's Medical Research Institute · AURoyal Brisbane and Women's Hospital · AUAlfred Health · AUBaker Heart and Diabetes Institute · AUPrince of Wales Hospital · AUUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The best available data indicate that the world is heading towards a pandemic of extensively drug-resistant Neisseria gonorrhoeae. At the same time, clinical microbiology laboratories have moved away from using culture-based methods to diagnose gonorrhoea, thus undermining our ability to detect antimicrobial resistance (AMR) using current technologies. In this Opinion article, we discuss the problem of N. gonorrhoeae AMR, particularly emerging resistance to the cephalosporin ceftriaxone, outline current concerns about the surveillance of N. gonorrhoeae AMR and propose the use of molecular methods on a large scale to systematically enhance surveillance.

Indexed as

Anti-Infective AgentsCeftriaxoneCephalosporinsDrug Resistance, BacterialEpidemiological MonitoringGenotypeGonorrheaHumansNeisseria gonorrhoeaeAnti-Infective AgentsCeftriaxoneCephalosporins

Identifiers

PMID24509781
OpenAlexW2031703906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.